BofA analyst Bryan Spillane lowered the firm’s price target on Estee Lauder to $205 from $235 and keeps a Neutral rating on the shares. BofA believes recovery in China is going slower than expected, and that the current recovery implies inventory overhang in China/Hainan is mitigated by February 2024, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EL:
- Estee Lauder to present preclinical results on anti-aging products at WCD
- Why Estée Lauder Stock (NYSE:EL) Has an Ace Up Its Sleeve
- Early notable gainers among liquid option names on June 14th
- Estee Lauder upgraded to Buy from Hold at Berenberg
- Activist Investor Peltz Exploring Estée Lauder’s (NYSE:EL) Makeover